Can explain why reduce paid up share capital is pretty good?
ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "COMPANY") CIRCULAR TO SHAREHOLDERS IN RELATION TO THE:
PART A PROPOSED REDUCTION OF THE ISSUED AND PAID-UP SHARE CAPITAL OF THE COMPANY PURSUANT TO SECTION 64 OF THE COMPANIES ACT, 1965 INVOLVING THE CANCELLATION OF RM0.05 OF THE EXISTING PAR VALUE OF THE ORDINARY SHARES OF RM0.10 EACH IN ABT TO RM0.05 EACH IN ABT;
PART B PROPOSED RATIFICATION FOR THE UTILISATION OF PROCEEDS FROM THE RIGHTS ISSUE WHICH WAS COMPLETED ON 28 APRIL 2014
SUN NEWS: Asia Bioenergy Technologies Bhd (AsiaBio) expects to better its performance in the current financial year ending March 31, 2016, as the group is actively managing its investments.
AsiaBio, which focuses on incubating start-up technology companies, particularly in the bio-energy sector, currently holds investments in Vsolar Group Bhd, Focus Dynamics Technologies Bhd, NetX Holdings Bhd and Carimin Petroleum Bhd.
“We have already reached our maximum in terms of investing in these companies. Right now we are looking at managing the investments, rather than making a new investment,” its executive director Steve Tan Sik Eek told reporters after its EGM yesterday.
“We are planning to turn them (the companies) around or at least give them an additional boost for the coming year. The plan is to move the companies to the next level, but it is hard to say on how well we will be doing going forward,” he added.
Given the current market scenario, Tan said it is a good time to look at recalibrating some of the strategies of the companies and cleaning up its business.
On prospects, Tan said he expects this year to be very challenging given the volatility of the market and current economic conditions.
“However we still think that the government’s commitment on the renewable energy sector is actually a very positive outlook,” Tan added.
AsiaBio registered a net loss of RM15.13 million for the second quarter ended Sept 30, 2015 (Q2FY16), with a revenue of RM10,000.
For the first six months, the group reported a net loss of RM25.32 million, with a revenue of RM6.48 million.
At the EGM, shareholders approved the company’s proposed reduction of its issued and paid-up share capital, through the cancellation of 5 sen of the par value of the ordinary shares of 10 sen each in the company to 5 sen each.
Shareholders also approved its proposed ratification for the utilisation of proceeds from the rights issue which was completed on April 28, 2014.
RESEARCH and development (R&D) incubator, Asia Bioenergy Technologies Bhd (AsiaBio), has developed a new microbial supplement for the rapid growth of plants, in a bid to curb the country’s over-reliance on food imports.
The supplement, called the “Plant ProBiotic Tumbuhan 2 in 1” (ProBiotic), which took two years to develop, has been proven to promote the growth of plant.
Treated plants show significant improvement nutrient absorption rate and have better root development. The supplement also improves soil conditions and helps get rid of antagonistic bacteria while improving yields and crop quality.
For the last two years, AsiaBio has been using ProBiotic on padi fields belonging to Pertubuhan Peladang Kawasan (PPK) Kampung Pelet and PPK Lahar Bubur, both in Penang, and the results have been significant.
“We used ProBiotic in Lahar Bubur in the first half of last year and not only did we manage to increase the yields by 108 per cent, the padi matured a month faster, meaning quicker harvest time and bigger profit,” said AsiaBio executive director Looi Kem Loong.
Experiments in different parts of the country have shown similar results, with Kampung Rama in Perlis registering an 88 per cent increase in yields — from 4,440kg of harvested crop to 8,300kg the following season.
“We see this technology as the way of the future and we intend to introduce this product to more farmers and food producers. It will help Malaysia’s food production in the long run,” said Steve Tan, who is also an AsiaBio executive director.
The firm has a lone production line at its Penang factory and is able to produce up to 1.5 tonnes of ProBiotic a month. It is looking to add four more production lines within 36 months.
“We have RM42 million worth of funds, so funding the production line is not an issue. The issue is in finding the markets for the supplement,” said Looi, adding that the firm intends to market its products domestically.
“Right now, we are looking at ways of getting promotional backing from the Agriculture and Agro-based Industries Ministry and the National Farmers Organisation, but this may take a while.”
However, both Looi and Steve are quite confident in getting the government’s backing in marketing ProBiotic to farmers nationwide, considering its proven benefits and the leadership of AsiaBio chairman Datuk Nur Jazlan Mohamed.
“We know that we have a working product that’s capable of yielding significant results. We also have the funding to increase our production capacity.
“We are waiting to get the market we need to push ProBiotic forward and that’s where we need the government’s backing the most,” said Tan.
AsiaBio was listed in 2009 as one of the five incubator companies, alongside OSK Ventures International Bhd and MCM Technologies Bhd, which is part of the AmCorp group of companies.
Revenue from ProBiotic is expected to become significant in the long term. It is currently being distributed by AsiaBio’s partner company, Artisan.
asiabio,nexgram,apft,sumatec,sanichi,kinsteel..ini semua karut je..memang ler murah,penny konter,sape yg baru masuk belajar saham,memang bersih ler duit kou,kena rembat ngan konter2 ni..haha..spender pun tak mampu beli kat bundle nanti.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Flybythenite
782 posts
Posted by Flybythenite > 2016-02-15 22:49 | Report Abuse
Can explain why reduce paid up share capital is pretty good?
ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "COMPANY") CIRCULAR TO SHAREHOLDERS IN RELATION TO THE:
PART A PROPOSED REDUCTION OF THE ISSUED AND PAID-UP SHARE CAPITAL OF THE COMPANY PURSUANT TO SECTION 64 OF THE COMPANIES ACT, 1965 INVOLVING THE CANCELLATION OF RM0.05 OF THE EXISTING PAR VALUE OF THE ORDINARY SHARES OF RM0.10 EACH IN ABT TO RM0.05 EACH IN ABT;
PART B PROPOSED RATIFICATION FOR THE UTILISATION OF PROCEEDS FROM THE RIGHTS ISSUE WHICH WAS COMPLETED ON 28 APRIL 2014